Der Perng Ming, Su Mu, Wen Shu Fang, Li Rong, Gibbon Terry, Prescott Alan R, Brenner Michael, Quinlan Roy A
School of Biological and Biomedical Sciences, The University of Durham, Durham, United Kingdom.
Am J Hum Genet. 2006 Aug;79(2):197-213. doi: 10.1086/504411. Epub 2006 Jun 12.
Here, we describe the early events in the disease pathogenesis of Alexander disease. This is a rare and usually fatal neurodegenerative disorder whose pathological hallmark is the abundance of protein aggregates in astrocytes. These aggregates, termed "Rosenthal fibers," contain the protein chaperones alpha B-crystallin and HSP27 as well as glial fibrillary acidic protein (GFAP), an intermediate filament (IF) protein found almost exclusively in astrocytes. Heterozygous, missense GFAP mutations that usually arise spontaneously during spermatogenesis have recently been found in the majority of patients with Alexander disease. In this study, we show that one of the more frequently observed mutations, R416W, significantly perturbs in vitro filament assembly. The filamentous structures formed resemble assembly intermediates but aggregate more strongly. Consistent with the heterozygosity of the mutation, this effect is dominant over wild-type GFAP in coassembly experiments. Transient transfection studies demonstrate that R416W GFAP induces the formation of GFAP-containing cytoplasmic aggregates in a wide range of different cell types, including astrocytes. The aggregates have several important features in common with Rosenthal fibers, including the association of alpha B-crystallin and HSP27. This association occurs simultaneously with the formation of protein aggregates containing R416W GFAP and is also specific, since HSP70 does not partition with them. Monoclonal antibodies specific for R416W GFAP reveal, for the first time for any IF-based disease, the presence of the mutant protein in the characteristic histopathological feature of the disease, namely Rosenthal fibers. Collectively, these data confirm that the effects of the R416W GFAP are dominant, changing the assembly process in a way that encourages aberrant filament-filament interactions that then lead to protein aggregation and chaperone sequestration as early events in Alexander disease.
在此,我们描述了亚历山大病发病机制的早期事件。这是一种罕见且通常致命的神经退行性疾病,其病理标志是星形胶质细胞中存在大量蛋白质聚集体。这些聚集体被称为“罗森塔尔纤维”,包含蛋白质伴侣αB-晶状体蛋白和HSP27以及胶质纤维酸性蛋白(GFAP),一种几乎仅在星形胶质细胞中发现的中间丝(IF)蛋白。最近在大多数亚历山大病患者中发现了杂合的错义GFAP突变,这些突变通常在精子发生过程中自发产生。在本研究中,我们表明更常观察到的突变之一R416W在体外显著干扰细丝组装。形成的丝状结构类似于组装中间体,但聚集性更强。与突变的杂合性一致,在共组装实验中,这种效应相对于野生型GFAP是显性的。瞬时转染研究表明,R416W GFAP在包括星形胶质细胞在内的多种不同细胞类型中诱导形成含GFAP的细胞质聚集体。这些聚集体与罗森塔尔纤维有几个重要的共同特征,包括αB-晶状体蛋白和HSP27的结合。这种结合与含R416W GFAP的蛋白质聚集体的形成同时发生,并且也是特异性的,因为HSP70不会与它们一起分配。针对R416W GFAP的单克隆抗体首次在任何基于中间丝的疾病中揭示了突变蛋白存在于该疾病的特征性组织病理学特征即罗森塔尔纤维中。总体而言,这些数据证实R416W GFAP的作用是显性的,以一种促进异常细丝-细丝相互作用的方式改变组装过程,进而导致蛋白质聚集和伴侣蛋白隔离,这是亚历山大病的早期事件。